NLS Pharmaceutics AG (NLSPW)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Apr 21, 2025, 9:30 AM

NLS Pharmaceutics AG Ratios and Metrics

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q2 2017
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Jun 30, 2017
PE Ratio	-40.43	-41.82K	-55.16	-43.82	-10.8	-22.3	-75.5	-85.49	-261.32	-158.47	-94.28	-1.5	-2.13	-184
PEG Ratio	0.40	1.41K	1.78	0.95	-1.35	-1.17	-3.21	-0.41	6.72	3.78	0.96	-0.04	n/a	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	-35.53	-86.34	-391.84	419.67	-92.37	1.21K	327.21	-62.01	-175.63	-208.72	-306.87	-0.00	n/a	n/a
P/FCF Ratio	-215.14	-319.41K	-230.21	-221.58	-48.7	-125.7	-142.36	-2.84K	-2.42K	-1.43K	1.81K	-17.6	-10.47	-901.94
P/OCF Ratio	-215.14	-319.41K	-230.21	-221.58	-48.7	-125.86	-142.84	-2.84K	-2.42K	-1.43K	1.81K	-17.6	-10.47	-901.94
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	-0.18	-0.18	n/a	n/a	-0.09	n/a	n/a	-0.23	-0.19	-0.14	-0.16	-0.8	n/a	n/a
Quick Ratio	0.15	0.23	0.59	2.76	0.61	2.40	6.95	0.04	0.05	0.09	0.45	0.04	n/a	n/a
Current Ratio	0.15	0.23	0.58	2.75	0.59	2.38	6.91	0.03	0.05	0.09	0.45	0.04	n/a	n/a
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	-23.61	-0.03	-58.52K	-74.1	-946.41	-7.32M	-66.67	-8.38	-12.25	n/a	-2.7	n/a	n/a	-6.48
Return on Equity	0.22	n/a	1.78	-2.39	2.14	-13.54	-1.08	0.18	0.17	0.33	0.81	n/a	n/a	n/a
Return on Assets	-1.71	n/a	-3.35	-0.85	-4.2	-1.27	-0.56	-1.34	-1.93	-2.92	-2.49	-0.02	n/a	n/a
Return on Invested Capital	0.43	n/a	4.65	-1.15	8.70	-2.18	-0.64	0.29	0.33	0.74	2.58	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a